OriginalAnálisis coste-utilidad de apixabán frente al ácido acetilsalicílico en la prevención del ictus en pacientes con fibrilación auricular no valvular en EspañaCost-effectiveness analysis of apixaban versus acetylsalicylic acid in the prevention of stroke in patients with non-valvular atrial fibrillation in Spain

Ginés Escolar Albaladejo,Gonzalo Barón-Esquivias,Jose Luis Zamorano,L. Betegón Nicolás,Cristina Canal Fontcuberta,Marina de Salas-Cansado,Darío Rubio-Rodríguez,Carlos Rubio-Terrés

OriginalAnálisis coste-utilidad de apixabán frente al ácido acetilsalicílico en la prevención del ictus en pacientes con fibrilación auricular no valvular en EspañaCost-effectiveness analysis of apixaban versus acetylsalicylic acid in the prevention of stroke in patients with non-valvular atrial fibrillation in Spain

2016

Ginés Escolar Albaladejo
Gonzalo Barón-Esquivias
Jose Luis Zamorano
L. Betegón Nicolás
Cristina Canal Fontcuberta
Marina de Salas-Cansado
Darío Rubio-Rodríguez
Carlos Rubio-Terrés

Objective To assess the cost-effectiveness of apixaban versus acetylsalicylic acid (ASA) in stroke prevention in patients with non-valvular atrial fibrillation (NVAF) with contraindications of vitamin K antagonists in Spain.

Keywords:

Stroke
Internal medicine
non valvular atrial fibrillation
vitamin k
Apixaban
in patient
Atrial fibrillation
cost effectiveness
Emergency medicine
Medicine
Cardiology
stroke prevention

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations